Substituted imidazol-pyridazine derivatives
US7005432B2 · kind B2 · utility
1Cited by
5References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 9, 2003 |
| Grant date | Feb 28, 2006 |
| Priority date | — |
| Expiry date | Aug 8, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula These compounds are NMDA NR-2B receptor subtype specific blockers and are useful in the treatment of neurodegeneration, depression and pain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.